• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

脂肪性肝病等位基因在尼安德特人中固定,在人类中呈中性分离。

fatty liver allele was fixed in Neanderthals and segregates neutrally in humans.

机构信息

Department of Medicine II, Division of Hepatology, University Hospital Wurzburg, Würzburg, Germany

Department of Medicine II, Division of Hepatology, University Hospital Wurzburg, Würzburg, Germany.

出版信息

Gut. 2024 May 10;73(6):1008-1014. doi: 10.1136/gutjnl-2023-331594.

DOI:10.1136/gutjnl-2023-331594
PMID:38458749
Abstract

OBJECTIVE

Fat deposition is modulated by environmental factors and genetic predisposition. Genome-wide association studies identified p.I148M (rs738409) as a common variant that increases risk of developing liver steatosis. When and how this variant evolved in humans has not been studied to date.

DESIGN

Here we analyse ancient DNA to track the history of this allele throughout human history. In total, 6444 published ancient (modern humans, Neanderthal, Denisovan) and 3943 published present day genomes were used for analysis after extracting genotype calls for p.I148M. To quantify changes through time, logistic and, by grouping individuals according to geography and age, linear regression analyses were performed.

RESULTS

We find that archaic human individuals (Neanderthal, Denisovan) exclusively carried a fixed risk allele, whereas allele frequencies in modern human populations range from very low in Africa to >50% in Mesoamerica. Over the last 15 000 years, distributions of ancestral and derived alleles roughly match the present day distribution. Logistic regression analyses did not yield signals of natural selection during the last 10 000 years.

CONCLUSION

Archaic human individuals exclusively carried a fixed allele associated with fatty liver, whereas allele frequencies in modern human populations are variable even in the oldest samples. Our observation might underscore the advantage of fat storage in cold climate and particularly for Neanderthal under ice age conditions. The absent signals of natural selection during modern human history does not support the thrifty gene hypothesis in case of p.I148M.

摘要

目的

脂肪沉积受环境因素和遗传易感性的调节。全基因组关联研究发现 p.I148M(rs738409)是一个常见的变异,增加了发生肝脂肪变性的风险。迄今为止,尚未研究该变异在人类中何时以及如何进化。

设计

在这里,我们分析古代 DNA,以追踪该等位基因在人类历史上的历史。总共分析了 6444 个已发表的古代(现代人、尼安德特人、丹尼索瓦人)和 3943 个已发表的现代基因组,在提取 p.I148M 的基因型后进行分析。为了定量随时间的变化,进行了逻辑回归和线性回归分析,将个体按地理和年龄分组。

结果

我们发现,古人类(尼安德特人、丹尼索瓦人)仅携带固定的风险等位基因,而现代人种的等位基因频率从非洲的极低到中美洲的>50%不等。在过去的 15000 年中,祖先和衍生等位基因的分布大致与当今的分布相匹配。逻辑回归分析在过去的 10000 年中没有产生自然选择的信号。

结论

古人类个体仅携带与脂肪肝相关的固定 等位基因,而现代人种的等位基因频率即使在最古老的样本中也存在差异。我们的观察结果可能强调了在寒冷气候下储存脂肪的优势,特别是在尼安德特人处于冰河时代条件下的优势。在现代人类历史上没有自然选择的信号并不支持 p.I148M 的节俭基因假说。

相似文献

1
fatty liver allele was fixed in Neanderthals and segregates neutrally in humans.脂肪性肝病等位基因在尼安德特人中固定,在人类中呈中性分离。
Gut. 2024 May 10;73(6):1008-1014. doi: 10.1136/gutjnl-2023-331594.
2
The PNPLA3 variant I148M reveals protective effects toward hepatocellular carcinoma in mice via restoration of omega-3 polyunsaturated fats.载脂蛋白基因 PNPLA3 变异体 I148M 通过恢复 ω-3 多不饱和脂肪对小鼠的肝细胞癌发挥保护作用。
J Nutr Biochem. 2022 Oct;108:109081. doi: 10.1016/j.jnutbio.2022.109081. Epub 2022 Jun 10.
3
Evaluation of the association of a variant in PNPLA3 and TM6SF2 with fibrosis progression in patients with chronic hepatitis C infection after eradication: A retrospective study.评估 PNPLA3 和 TM6SF2 变异与慢性丙型肝炎感染患者根除后纤维化进展的相关性:一项回顾性研究。
Gene. 2022 Apr 30;820:146235. doi: 10.1016/j.gene.2022.146235. Epub 2022 Feb 7.
4
The variability of PNPLA3 gene as a potential marker of cold adaptation in Yakuts.PNPLA3 基因的变异性作为雅库特人冷适应的潜在标志物。
Int J Circumpolar Health. 2023 Dec;82(1):2246647. doi: 10.1080/22423982.2023.2246647.
5
Clinically silent LINE 1 insertion in the PNPLA3 gene may impede genotyping of the p.I148M variant.PNPLA3 基因中临床无沉默的 LINE1 插入可能会阻碍 p.I148M 变异型的基因分型。
Sci Rep. 2021 Oct 22;11(1):20924. doi: 10.1038/s41598-021-00425-0.
6
Hepatic patatin-like phospholipase domain-containing 3 levels are increased in I148M risk allele carriers and correlate with NAFLD in humans.肝型脂肪酶相关磷酸酶结构域蛋白 3 水平在 I148M 风险等位基因携带者中升高,并与人类的非酒精性脂肪性肝病相关。
Hepatol Commun. 2022 Oct;6(10):2689-2701. doi: 10.1002/hep4.2032. Epub 2022 Jul 14.
7
The I148M PNPLA3 polymorphism influences serum adiponectin in patients with fatty liver and healthy controls.I148M PNPLA3 多态性影响脂肪肝患者和健康对照者的血清脂联素。
BMC Gastroenterol. 2012 Aug 16;12:111. doi: 10.1186/1471-230X-12-111.
8
African genetic ancestry is associated with lower frequency of PNPLA3 G allele in non-alcoholic fatty liver in an admixed population.非洲遗传血统与混合人群中非酒精性脂肪性肝病中 PNPLA3 G 等位基因的低频率相关。
Ann Hepatol. 2022 Nov-Dec;27(6):100728. doi: 10.1016/j.aohep.2022.100728. Epub 2022 Jun 13.
9
Chronic overexpression of PNPLA3I148M in mouse liver causes hepatic steatosis.慢性过表达 PNPLA3I148M 于小鼠肝脏中可导致肝脂肪变性。
J Clin Invest. 2012 Nov;122(11):4130-44. doi: 10.1172/JCI65179.
10
ABO Genetic Variation in Neanderthals and Denisovans.尼安德特人和丹尼索瓦人 ABO 基因变异。
Mol Biol Evol. 2021 Jul 29;38(8):3373-3382. doi: 10.1093/molbev/msab109.

引用本文的文献

1
Fifteen Years of PNPLA3: Transforming Hepatology Through Human Genetics.PNPLA3的十五年:通过人类遗传学改变肝病学
Liver Int. 2025 Sep;45(9):e70240. doi: 10.1111/liv.70240.
2
Lower Frequency of Polymorphism in West African Populations and Divergent Associations With Hepatocellular Carcinoma.西非人群中多态性频率较低以及与肝细胞癌的不同关联
Gastro Hep Adv. 2025 Feb 9;4(6):100639. doi: 10.1016/j.gastha.2025.100639. eCollection 2025.
3
Bridging the gap in obesity research: A consensus statement from the European Society for Clinical Investigation.
弥合肥胖研究差距:欧洲临床研究学会的共识声明
Eur J Clin Invest. 2025 Aug;55(8):e70059. doi: 10.1111/eci.70059. Epub 2025 May 15.
4
Metabolic Syndrome and Somatic Composition: A Large Cross-sectional Analysis.代谢综合征与身体组成:一项大型横断面分析。
In Vivo. 2025 Jan-Feb;39(1):381-389. doi: 10.21873/invivo.13839.
5
Global Epidemiological Impact of PNPLA3 I148M on Liver Disease.PNPLA3 I148M对肝脏疾病的全球流行病学影响。
Liver Int. 2025 Mar;45(3):e16123. doi: 10.1111/liv.16123. Epub 2024 Oct 7.
6
Liver Diseases: Science, Fiction and the Foreseeable Future.肝脏疾病:科学、虚构与可预见的未来
J Pers Med. 2024 May 4;14(5):492. doi: 10.3390/jpm14050492.